About

PMI Contributions to Fight Malaria

Background

Photograph of an African woman holding hands with her smiling daughter in front of a rugged landscape, while carrying an Insecticide-Treated Net. Photo Credit: Riccardo Gargale, VectorWorks. Courtesty of Photoshare.

Source: Riccardo Gangale, VectorWorks.

When it was launched in 2005, the goal of the President’s Malaria Initiative (PMI) was to reduce malaria-related mortality by 50 percent across 15 high-burden countries in sub-Saharan Africa through a rapid scale-up of four proven and highly effective malaria prevention and treatment measures: insecticide-treated mosquito nets (ITNs); indoor residual spraying (IRS); accurate diagnosis and prompt treatment with artemisinin-based combination therapies (ACTs); and intermittent preventive treatment of pregnant women (IPTp). See PMI Technical Guidance [PDF, 2.4MB] to learn more.

With the passage of the Tom Lantos and Henry J. Hyde Global Leadership against HIV/AIDS, Tuberculosis, and Malaria Act in 2008 [PDF, 239KB], PMI developed a U.S. Government Malaria Strategy for 2009–2014 [PDF, 483KB]. Consistent with this strategy and the increase in annual appropriations supporting PMI, four new countries in sub-Saharan Africa and one regional program in the Greater Mekong Subregion of Southeast Asia were added in 2011.

PMI’s Strategy for 2015–2020 [PDF, 15.9MB] takes into account the progress over the past decade and the new challenges that have arisen. Malaria prevention and control remains a major U.S. foreign assistance objective and PMI's Strategy fully aligns with the U.S. Government's vision of ending preventable child and maternal deaths and ending extreme poverty. It is also in line with the goals articulated in the Roll Back Malaria Partnership's Action and Investment to Defeat Malaria 2016–2030 and World Health Organization's Global Technical Strategy for Malaria 2016–2030. Under the PMI Strategy for 2015–2020, the U.S. Government's goal is to work with PMI-supported countries and partners to further reduce malaria deaths and substantially decrease malaria morbidity, towards the long-term goal of elimination. In FY 2017, thanks to increased funding for PMI from the U.S. Congress, PMI announced plans for a five-country expansion adding programs in Burkina Faso, Cameroon, Côte d’Ivoire, Niger and Sierra Leone, which grew PMI’s reach to 24 malaria-endemic countries in sub-Saharan Africa, including those with the highest burden, and three programs in the Greater Mekong Subregion of Southeast Asia.

Structure

PMI is an interagency initiative led by the U.S. Agency for International Development (USAID) and implemented together with the U.S. Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS). It is overseen by a U.S. Global Malaria Coordinator and an Interagency Advisory Group made up of representatives of USAID, CDC/HHS, the Department of State, the Department of Defense, the National Security Council, and the Office of Management and Budget.

PMI partners

Leadership

Irene Koek

Senior Deputy Assistant Administrator
Acting U.S. Global Malaria Coordinator

Portrait of Irene KoekIrene Koek is currently the senior deputy assistant administrator in USAID's Global Health Bureau. Prior to this, she was the senior Infectious disease advisor for the Global Health Bureau and the Global Health Security Agenda lead at USAID. From 2010-2014 she was director of the Health Office in USAID/Indonesia where she also served as health attaché and PEPFAR coordinator. After her return to Washington from Indonesia and until April 2015, Ms. Koek served as the deputy director of the Office of Population and Reproductive Health in the Global Health Bureau.

Koek joined USAID in 1986. Starting in the Office of Population, she moved to the Policy and Program Coordination Bureau in 1995 as a health advisor, addressing maternal and child health, family planning and infectious disease issues. In 1998, Ms. Koek became the chief of the Infectious Disease Division in the Global Health Bureau, overseeing staff and programs for malaria, tuberculosis and neglected tropical diseases. In that role, she helped to start the President's Malaria Initiative and served as chair of the Stop TB Coordinating Board. Ms. Koek has a Master of Arts degree from George Washington University.


Funding

The PMI funding figures below do not include other U.S. Government funding for malaria activities from the U.S. Agency for International Development (USAID), the U.S. Centers for Disease Control and Prevention (CDC), the National Institutes of Health or the Department of Defense.

Fiscal Year (FY) Budget Focus Countries
2006 $30 million Angola, Tanzania, and Uganda
2007 $154 million + Malawi, Mozambique, Rwanda, and Senegal
2008 $296 million + Benin, Ethiopia (Oromia Region), Ghana, Kenya, Liberia, Madagascar, Mali, and Zambia 
2009 $300 million 15 PMI focus countries
2010 $500 million 15 PMI focus countries
2011 $578 million + DRC, Nigeria, Guinea, Zimbabwe and the Mekong Subregion 
2012 $604 million 19 PMI focus countries and three programs in the Greater Mekong Subregion
2013 $608 million 19 PMI focus countries and three programs in the Greater Mekong Subregion
2014 $619 million 19 PMI focus countries and three programs in the Greater Mekong Subregion
2015 $619 million 19 PMI focus countries and three programs in the Greater Mekong Subregion
2016 $621 million 19 PMI focus countries and three programs in the Greater Mekong Subregion
2017 $723 million 24 PMI focus countries and three programs in the Greater Mekong Subregion

Country Selection: The 24 countries in Africa were selected and approved by the U.S. Global Malaria Coordinator and the Interagency Steering Group using the following criteria: high malaria disease burden; national malaria control policies consistent with the internationally accepted standards of the World Health Organization; national capacity to implement such policies; willingness to partner with the U.S. to fight malaria; involvement of other international donors and partners in national malaria control efforts. 

Partners

A family in Cambodia smile for the camera in front of a mosquito net. Photo credit: Kharn Lina, URC

Source: Kharn Lina, URC.

Partnerships at national and international levels are key to the success of PMI’s malaria control efforts. PMI’s investments are strategically targeted to support each focus country’s malaria control strategy and plan while coordinating with and leveraging the support of other partners including:

  • Multilateral and bilateral organizations
  • Other U.S. Government agencies and initiatives
  • Private sector partners
  • Foundations
  • Community-based organizations
  • Implementing partners

Results

A group of mosquito sprayers unload a truck and prepare to work. Photo credit: Brant Stewart, RTI.

Source: Brant Stewart, RTI.

The U.S. Government’s leadership and its financial and technical contributions through PMI have been central to the remarkable achievements against malaria. The World Health Organization estimates global efforts have helped reduce malaria deaths by more than 60 percent, saving almost 7 million lives, and preventing more than 1 billion malaria cases between 2000 and 2015.

In PMI focus countries, the gains in malaria control have been impressive since PMI was first launched in June 2005. To date, excluding the five new PMI countries announced in 2017, all 19 PMI focus countries in Africa have data from paired nationwide surveys and have documented declines in all-cause mortality rates among children under five (see Figure below). The large-scale rollout of malaria prevention and treatment measures across sub-Saharan Africa during the past decade has been an important factor in these child survival improvements.

For details on PMI's decade of progress, access the PMI Twelfth Annual Report – April 2018 [PDF, 2.7MB], or take a quick view of PMI by the Numbers [PDF, 2.7MB].

Reduction in All-Cause Mortality Rates of Children Under Five Years of Age in PMI Focus Countries